| Serial Number | 90733679 |
| Word Mark | MAB2 |
| Filing Date | Tuesday, May 25, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 15, 2023 |
| Registration Number | 7135330 |
| Registration Date | Tuesday, August 15, 2023 |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, May 30, 2023 |
| Description of Mark | The mark consists of the lower case letter "M" followed by an upper case letter "A" followed by a lower case letter "B" with a superscript "2" following the "B". |
| Goods and Services | Pharmaceutical, biopharmaceutical and medical preparations, agents and substances, all containing or being monoclonal antibodies for medical purposes, and all for treatment of cancer, oncological diseases and disorders, infectious diseases and disorders, inflammation and diseases, disorders and conditions associated with inflammation, inflammatory diseases and disorders, and neurological diseases and disorders; bispecific and multispecific monoclonal antibodies for medical use; products in the nature of pharmaceutical preparations and medicines containing multispecific, in particular bispecific, monoclonal antibodies for use in medicine; diagnostic preparations, agents and substances, all containing or being monoclonal antibodies, for medical purposes |
| Pseudo Mark | MAB TWO |
| Goods and Services | Biological preparations containing monoclonal antibodies for scientific, industrial, and research use; bispecific and multispecific monoclonal antibodies, and fragments thereof, for scientific, industrial, and research use |
| Goods and Services | Scientific and technological services, namely scientific research and design in the field of immunoglobulins and antibodies for medical purposes; scientific research, namely industrial analysis and research services, in the field of immunoglobulins and antibodies for medical purposes; pharmaceutical, scientific and biopharmaceutical research and development; medical research and development in the field of immunoglobulins and antibodies for medical purposes; drug discovery services; research relating to medicines; research and development of medicines; development of pharmaceutical and biopharmaceutical preparations and medicines; all of the foregoing involving monoclonal antibodies |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 27, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 20, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 20, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | INVOX PHARMA LIMITED |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 11 - Company |
| Address | WHITE CITY PLACE W12 7FQ GB |
| Party Name | F-STAR THERAPEUTICS LIMITED |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CAMBRIDGE, CB22 3AT GB |
| Party Name | F-STAR THERAPEUTICS LIMITED |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CAMBRIDGE, CB22 3AT GB |
| Party Name | F-STAR THERAPEUTICS LIMITED |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 99 - Other |
| Address | CAMBRIDGE, CB22 3AT GB |
| Party Name | F-star Biotechnology Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge CB223AT GB |
| Event Date | Event Description |
| Friday, May 28, 2021 | NEW APPLICATION ENTERED |
| Friday, August 20, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, February 7, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, February 8, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, February 8, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, February 8, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, May 19, 2022 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Thursday, July 28, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, July 28, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 28, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, August 16, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, September 20, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 20, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, September 20, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 20, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 20, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 21, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, April 27, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, April 27, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, April 27, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, April 27, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, April 27, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 10, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 30, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 30, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 15, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, August 15, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, October 30, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |